RecruitingPhase 4NCT06271707

Stellate Ganglion Block

Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study


Sponsor

University of Minnesota

Enrollment

48 participants

Start Date

May 19, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria1

  • Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.

Exclusion Criteria3

  • Patients who have an exclusion to regional anesthesia.
  • Patients who have exclusion to stellate blockade.
  • Patients who are pregnant assessed via self-report or pregnancy test if they have taken one

Interventions

DRUG0.5% bupivacaine

an ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine

OTHERSaline

an ultrasound guided left stellate ganglion block with 5 mL of saline


Locations(1)

University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06271707


Related Trials